Gene Ther Mol Biol Vol 4,
11-22. December 1999.
Somatic cell nuclear transfer as a tool for investigating ageing processes in mammals
Review Article
PPL Therapeutics, Roslin, Edinburgh EH25 9PP,
Scotland
______________________________________________________________________________________
Correspondence: Tel: +44(0)131 440-4777; Fax:
+44(0)131 440-4888; E-mail: pshiels@ppl-therapeutics.com
Key words: Mammalian cloning, nuclear transfer,
ageing, aging, oxidative damage, telomere, rDNA, mitochondria. nucleolus
The development of nuclear transfer technology has opened up a new frontier in the investigation of the processes which contribute to ageing in mammals. This review seeks to assess the individual hypotheses that have been proposed to account for the development of the ageing phenotype and to ask how they correlate with observations made on cloned mammals. In sheep derived by nuclear transfer there appears to be prematurely shortened telomeres, indicative of increased age. The animals, however, are physiologically normal, consistent with a redox model of ageing where mitochondrial damage is the key contributory factor. The application of nuclear transfer technology to the study of ageing phenomena and its use in experimentally redressing aspects of the ageing phenotype is discussed.
Ageing can be defined as
an increase in molecular chaos over time. This is generally manifest as a
change in phenotype and an associated exponential increase in the likelihood of
mortality. The latter part of that definition was first described by Gompertz
(1825), but it has only been in more recent times that the molecular and
cellular events giving rise to the
age related phenotypic changes have begun to be unraveled. The seminal work of
Hayflick and Moorehead (1961) in describing replicative senescence for human
fibroblasts in vitro, gave a new impetus to studies in gerontology and has paved
the way for a description of the molecular basis of ageing.
Contemporary
investigations in the nematode Caenorhabditis elegans and in lower eukaryotes, principally
Saccharomyces cerevisiae (reviewed by Guarente, 1997), have given direct insight
into which genes and molecular processes underlie the basis of ageing at the
cellular level and provide a basic paradigm for ageing in higher
organisms. The most celebrated
model of ageing is still, however, based upon in vitro senescence data and
centres around telomere shortening as a molecular clock. Other molecular models have been proposed, based on oxidative damage and
fragmentation of mitochondrial DNA (reviewed by Ozawa 1997; Osiewacz, 1997), or
upon age dependent demethylation of DNA. These are not necessarily mutually exclusive,
but all require critical testing in vivo.
Nuclear transplantation
provides a powerful tool for examining the relationship between age related
changes at the molecular level and ageing in the whole animal. The advent of
Dolly, derived by nuclear transplantation of an adult nucleus from a mammary
cell of a six year old animal (Wilmut et al, 1997), provides for the first time, the ability to directly test
these models in an in vivo context. The
facility to recreate a higher organism while circumventing the germline and
potentially, the resetting of any molecular clocks, provides a new approach to
the investigation of the relationship between factors determining physiological
age and cellular senescence.
The telomere hypothesis
of cellular ageing (Olovnikov,
1973; Cooke and Smith, 1986; Harley, 1991; Bodnar et al. 1998) espouses that the
loss of telomeric DNA through incomplete replication of chromosome ends and
lack of telomerase to repair damage, provides a mitotic clock that eventually
signals cell death. Once a critical loss of telomeric sequences has occurred
from the chromosome ends, replicative capacity is compromised and the cell
dies. Telomere shortening has been causally implicated in human cellular
senescence (Harley et al 1990; Allsopp et al, 1992), disease (Oexle and
Zwirner, 1997) and by general
implication, the physiological ageing process in higher animals.
Telomeres are specialised structures found at the end of eukaryotic chromosomes, consisting of simple
repetitive DNA; in mammals telomeres
comprise (TTAGGG)n (Moyzis et al, 1988). They have at least
three roles in the maintenance of chromosome structure and integrity, (i) a
capping function that is to protect DNA ends from fusion, recombination and
degradation, (ii) attachment of the chromosome to the nuclear envelope and
(iii) facilitation of the complete replication of chromosome ends (Olovnikov
1973). In man, the latter is
achieved via the mediacy of a unique ribonucleoprotein complex, termed telomerase, which has the
capacity to synthesise telomeric DNA de novo onto the 3’ end of the parental G rich strand, using
the telomerase RNA component as template. This then allows DNA polymerase to
conventionally complete the synthesis of the daughter strand. Telomerase
principally functions in the human germ line, stem cells and haemopoeitic
cells, but not in somatic tissues where telomere damage accumulates over time.
Consequently, telomeres in man shorten during replicative ageing (Cooke and
Smith, 1986; de Lange, 1992; Frenck et al, 1998).
The telomere capping
function appears to be mediated by a combination of a unique tertiary structure
and specific telomere binding proteins. Conventionally, this was thought to be
achieved either by a specific DNA binding protein attaching to the linear
chromosome end (Gottschling and Zakian, 1986) or by a distinct structure
composed of a quartet of G residues at the single stranded terminus of the
telomere (Williamson et al, 1989). As yet, there has been no direct in vivo evidence for either of these features in
higher eukaryotes.
Electron microscopy has
shown that the mammalian telomere takes the form of a loop, termed the t-loop,
created by the telomere DNA folding back on itself to form a lariat whose
leading end is the telomeric
3’ G strand overhang. This is envisaged as invading adjacent
duplex telomeric repeats, thus creating a displacement loop (D loop). Duplex
DNA binding proteins are proposed
to bind along the telomeric repeats of the t-loop, while a specialised DNA
binding protein stabilises the D-loop lariat junction (Griffith et al, 1999).
This is illustrated in Figure 1.
Reconciliation of a
telomere based model of ageing and cellular senescence with a telomere
structure based on a t-loop, poses
some intriguing questions.
Does, for example,
encasement within the duplex serve to distinguish the terminal sequence from
damage accrued DNA breaks?
Physical isolation of the telomere from normal DNA damage responses would have a number of
implications for models seeking to explain the loss and gain of telomeric DNA.
Figure 1. Hypothesised structure for mammalian
telomeres.
The telomere is proposed to loop back upon itself with the 3’ overhang
invading the adjacent duplex creating a displacement loop (D-loop) which
is stabilised by specific telomere binding proteins (
yellow ovoids). Other duplex DNA binding protein complexes (red ovoids) are
proposed to engage along the t-loop stabilising the whole structure.

In the first instance,
the presence of the 3’ G strand extension of the telomere within the
telomeric duplex, can be construed as being representative of an intermediate
event during the process of
recombination. This could theoretically potentiate DNA loss via branch migration
and subsequent degradation of
single stranded DNA segments. Gain
of telomeric DNA is also possible if the 3’ invading strand initiates the
priming of de novo DNA synthesis subsequent to strand invasion. These
mechanisms are not without
precedent . Two alternative mechanisms to initiate DNA replication, one
dependent on Escherichia coli RNA polymerase the other dependent on general
recombination, have been reported for bacteriophage T4 (Luder and Mosig, 1982).
Such mechanisms may contribute to telomere dynamism, particularly in the
context of telomerase negative cells, where alternative telomere lengthening (ATL)
mechanisms have been reported (Kipling. and Cooke 1990; Starling et al, 1990; Prowse and
Greider, 1995).
A loop structure also has
consequences for telomerase function. How, for example, does telomerase gain
access to the terminal sequence? It is not intuitive that having a terminal
sequence buried within a D loop and stabilised by bound proteins is a readily accessible substrate. Does
this singular structure act as a beacon for the telomerase holoenzyme? The
implication is that for telomerase to access the terminus, there may be
inherent dynamism in the loop during replication.
Analysis of senescence in
Saccharomyces cerevisiae has led to the development of a strikingly simple model to
explain senescence in yeast, which may be applicable to ageing in higher
organisms. Mutants for the SGS 1 gene, which codes for a yeast Rec
Q-like helicase, senesce prematurely and show a characteristic accumulation of
extrachromosomal rDNA circles in mother cells following successive asymmetric cell divisions,
which leads to cell death (Sinclair and Guarente, 1997).
The accumulation of
extrachromosomal rDNA circles is accompanied by nucleolar fragmentation
(Sinclair et al 1997) and a disruption of silencing complexes at telomeres and
HM silent mating type loci. These silencing complexes are composed of Sir
proteins and appear to promote longevity. Deletion of component members, such as
Sir 3 or Sir 4 results in shortened lifespan. A consequence of their disruption
is the relocation of Sir 3 and Sir
4 proteins into the nucleolus (Kennedy et al 1997). Whether this is a direct
response to the accumulation of the rDNA circles or events associated with
their formation, is not fully determined.
The telomeric location of
Sir protein complexes and their involvement in regulating telomere length and
telomeric silencing, coupled with a role in ageing, is intriguing, especially
in view of the correlation between telomere shortening and ageing in
mammals. In S. cerevisiae, however, telomeres do
not shorten with age, and an inverse correlation between telomere length and
lifespan has been observed (Austriaco and Guarente1997). Conversely, telomere length
in yeast correlates positively with telomere silencing. In the absence of
telomere erosion with age, longer
telomeres could be envisaged as better competitors for silencing complexes,
with resultant exacerbation of rDNA circle generation. These observations are not irreconcilable with observations in
mammals where telomere shortening occurs with increasing age. In this instance
the release of Sir complex analogues for recruitment to nucleolar or other sites
would result as a consequence of telomere erosion. Thus when viewed from the
perspective of the whole organism, telomere shortening, rather than acting as a molecular clock
in mammals, may be a homeostatic mechanism to prolong lifespan. As yet, there are no reports of
extrachromosomal rDNA circles for ageing mammalian cells. It will be
interesting to see if mammalian species with longer lifespans do indeed all
have relatively longer telomeres.
Significantly, SGS1 is
the homologue of WRN in man, the gene
responsible for Werners syndrome, a premature ageing condition, hence the
possibility that a similar derangement of rDNA sequences is contributory to
human ageing. Interestingly, the WRN protein has a central domain which is homologous to members of the
RecQ family of DNA helicases and has been shown to catalyse DNA unwinding (Gray
et al 1997), which is in keeping with the role of SGS 1 in yeast.
Ageing as a consequence
of cumulative molecular insults has formed the basis of a number of models over
the past 40 years. DNA based models of ageing (Alexander 1967; Ozawa,
1995.1997) operate on the premise that oxidative damage to DNA should increase
with age and result in decreased functional capacity, inclusive of the ability
to repair oxidative damage. By extension, models which propose that the
principal agents of DNA damage are free radicals generated as a by-product of
oxidative metabolism would predict
that mammals with lower metabolic rates should have an increased lifespan and a
decreased rate of accumulation of somatic damage compared to those with higher metabolic rates.
Experimental evidence in support of such a hypothesis is widespread, though
circumstantial. An inverse correlation between lifespan and metabolic rate has
been observed in mammals (Cathcart et al 1984). For exaple, rats who have a higher metabolic rate than man,
have a shorter life span and a higher rate of accumulation of free radical
engendered DNA damage. These
differences are more pronounced in the mouse, whose lifespan is even shorter
and metabolic rate higher than that of the rat. Analysis in monkeys again
correlates well with this hypothesis (Adelman et al 1988).
Rodents do show a
comparatively higher age related increase in DNA oxidative damage
products, such as
8-hydroxy-2’-deoxyguanine (8-OHdG) (Fraga et al 1990: Sohal et al 1994).
Significantly, the levels of such DNA damage products can be reduced by
calorific restriction, which has
been shown to increase longevity
in rats and mice (Sohal et
al 1994). Dietary restriction
would be expected to have an influence on a wide range of genes (Mote et al
1991), including those involved in oxidative metabolism (e.g. superoxide
dismutase, catalase) through the generation of cellular stress responses. Indeed, cells from calorifically
restricted animals maintain replicative potential longer in vitro than those from ad librum fed controls, which is consistent with
a loss of replicative potential in vivo being associated with cumulative oxidative insults (Hass et
al, 1993).
Studies on cells derived
from progeric Werners syndrome patients are also consistent with a model, in
which the products of oxidative damage accumulate through lack of
sufficient DNA repair. Cells from
these patients display hyper-recombination, increased mutation frequency and a
propensity for large deletions (Fukuchi et al 1989; Cheng et al 1990). WRN
patients also present with a high incidence of rare malignancies (Goto et al
1996), consistent with a defect in DNA repair processes which probably relates
to the helicase function of the WRN protein (Gray et al 1997). This is
supported by observations on another progeric condition, Cockayne’s
syndrome, which similarly displays characteristic defects in DNA repair (van Gool et al 1997).
Most DNA repair
syndromes, however, do not show
features typical of progeria and, in contrast to the above observations, it has
been reported that in vitro DNA repair capacity is not affected by age
(Kunisada et al 1990). These authors studied the repair
capacity of human fetal lung fibroblasts and primary embryo fibroblast cultures
from rat lung and skin, for their capacity to repair a reporter plasmid which
had been UV irradiated prior to transfection. Neither age-related, nor change
as a function of passage number was found in the repair of UV damage in these
cells.
These data remain to be
reconciled with previous observations, as they appear counter-intuitive. The
data may reflect elevated stress
responses as a consequence of cell culture or, more significantly, reflect DNA
repair capacity in relation to the stage of senescence of immortalised cells in
vitro or senescing primary cell cultures.
It may not be sufficient to extrapolate these observations to in
vivo age related changes in DNA repair
capacity.
A stronger correlate for
models of ageing based on oxidative damage can be found in the examination of mitochondrial DNA
(mtDNA). A decrease in
mitochondrial respiratory activity and an increase in mitochondrial mutations
and fragmentation has been positively associated with increasing age (Linnane
et al, 1989,1990; Hayakawa et al 1992). Oxidative damage to mtDNA may have more
pronounced effects, as mitochondria in post mitotic cells maintain the capacity
to replicate (Menzies and Gold 1971), hence, the potential exists to generate and
accumulate deleterious mutations which become fixed in the cell population and
lead to respiratory deficiency and degeneration. These ideas have been
incorporated into “the redox mechanism of ageing” (Ozawa
1995,1997), which hypothesises a molecular basis for the age related decline in
cellular activity, tissue and organ degeneration and age associated
deterioration in cognitive performance.
Mitochondrial mutations are proposed to arise afresh each generation and
accrue with age. These mutations are proposed to correlate directly with
oxidative damage and cell death. The level of accumulated mutations is
considered to directly equate with age related decline in cellular function.
While many aspects of
this hypothesis seem intuitive, evidence in support of it still remains largely
circumstantial. The
pronounced age related
accumulation of 8-OHdG in mtDNA
relative to nuclear DNA (Hayakawa et al 1992) and a correlation with a decline
in the mitochondrial electron transfer chain (Hayakawa et al 1993; Takawasa et
al 1993) support the hypothesis.The results of elevated stress resulting from
mitochondrial mutations have also been observed clinically in patients with
mitochondrial myopathy (Ozawa et al 1995) and in murine models of mitochondrial
disease (Esposito et al 1999).
Direct confirmation of
this hypothesis at an organismal level and its integration with other models of
ageing, is a facinating prospect.
It is not immediately obvious, for example, how redox theories of ageing
can be incorporated into a genetic model
of ageing, such as that for the klotho mouse (Kuro-o et al 1997). The
latter is especially intriguing as the mouse presents with a progeric syndrome
with many features in common with human ageing including infertility,
arteriosclerosis, osteoporosis, emphysema and skin atrophy. Surprisingly, these
all result from the function of a single mutant gene with similarity to b-glucosidase. Whether the klotho mouse actually represents a true ageing
syndrome or is simply a good model for diseases of ageing is undetermined. The
investigation of such a genetic model, in the context of current hypotheses of
ageing, should prove worthwile
given that only a single
gene is responsible for the klotho phenotype.
The rate of loss of DNA
5-methyldeoxycytidine residues appears to be inversely related to lifespan (
Wilson and Jones 1983; Wilson et al, 1987). Losses in genomic
5-methyldeoxycytidine content have been observed to correlate with donor age in
cultured normal human bronchial epithelial cells and in vivo derived murine genomic
DNA (Wilson et al, 1987). Conversely, the level of DNA 5-methyldeoxycytidine
appears relatively stable in immortalised cells. Significant losses of DNA
5-methyldeoxycytidine residues in old age could alter cellular gene expression
and contribute to the physiological decline of the animal. Treatment of cells with agents that induce
random hypo-methylation induce premature senescence (Gray et al 1991).
This correlation between
accelerated DNA demethylation and accelerated ageing, while suggesting that
these two phenomena are related, does not indicate direct causation. DNA
demethylation during ageing may not be random, and could co-operate with other
independent ageing processes to produce a finite lifespan and age associated
phenotype. In both instances, accelerated DNA demethylation could advance
ageing, though in vivo this may not be a reflection of the overall level of
genomic 5 methyldeoxycytidine, but
rather the perturbation of function of specific gene(s). Furthermore, methylation is thought to stabilise heterochromatin and loss
of methylation with age in vivo, or in vitro , may correlate with the
loss of telomeric heterochromatin. As such, age related loss of methylation is
not incongruous with other models of ageing, in particular those involving
erosion or destabilisation of telomeres.
III. In vivo analysis of ageing.
Analysis of in vivo ageing has never been
straight-forward. Critical testing
of the various hypotheses to account for ageing in eukaryotes has generally relied on inter-generational
comparisons or between mutant and wild type animals. Many investigations simply extrapolate from in vitro data. Such experiments have produced a
wealth of information on the molecular processes involved in ageing, but they
cannot be extricated from the
influence of endogenous molecular clocks (e.g. telomere length), variation in genetic background and artefacts
arising from in vitro senescence
phenomena. Consequently, the
ability to distinguish between the relative contributions of genetic and
structural damage, a reasonable
prerequisite for the formulation
of an accurate model of in vivo
ageing,
is not readily addressed in
previous analyses.
Accordingly, a
comprehensive and integrated determination of the contributions of the individual molecular processes to
the ageing phenotype has not been achieved.
The development of
nuclear transfer (NT) using cultured somatic cells (Campbell et al, 1996; Wilmut et
al, 1997; Schnieke et al., 1997; Wells et al , 1997; Ashworth et al., 1998; Signer et al., 1998; Cibelli et
al., 1998;
Wakayama et al 1998) offers a new
analytical approach. It advances the possibility of viewing age related
changes, both at the single cell level and at the level of the whole organism,
against a uniform genetic background with circumvention of any molecular
clock(s) reset in the germline.
Importantly, it allows dissection of the relationship between ageing
processes at both these levels.
Aspects of the nuclear
transfer procedure impinge directly upon the central tenets of current theories
of ageing which can now be subject to integral analyses. Critical to such
analyses is the ability to compare clones at different chronological ages,
either in vivo, or in vitro, in order to assay directly age
related phenomena. Significantly, this is independent of the age of the
progenitor tissue. The capacity to serially derive animals (i.e.: clones of
clones) by NT (Wakayama and Yanagimachi, 1999) and
to genetically manipulate the cell prior to nuclear transplantation (Schnieke
et al 1997), increases the power of the possible investigations. This offers
the capability of restoring telomerase activity to previously telomerase
negative cells, knocking out or mutating genes implicated in the ageing
process, such as klotho, free radical scavengers or nuclear encoded
mitochondrial genes, to name but a few.
Importantly, nuclear
transfer results in the separation of the nucleus from the mitochondria of the
progenitor cell during the transplantation procedure. The relative
contributions of genomic and mitochondrial damage and how these are manifest in
the ageing organism can now be addressed.
The obvious sequitur from
the use of nuclear transfer as a
tool to investigate ageing processes will be to ask if any of these processes
are reversible. For example, can telomere erosion be repaired? Can one mitigate
the effects of nuclear oxidative damage? Can mitochondrial function be
restored?
A. Mammalian clones
To date four mammalian
species have been used to successfully derive clones by nuclear
transplantation; these comprise sheep (Campbell et al, 1995; Wilmut et al,
1997), cattle (Wells et al 1997; Cibelli et al 1998), mice (Wakayama et al
1998) and goats (Baguisi et al 1999). The methodological considerations
and general applications of
cloning have been reviewed extensively elsewhere (Campbell 1999, Colman 1999).
An outline of the nuclear transfer procedure is shown in Figure 2.
The creation of Dolly (Wilmut et al,
1997) was of particular significance to studies of ageing in that the
progenitor nucleus was not only derived from a somatic cell type, but from a
six year old adult. Whilst these authors were unable to confirm whether the
cell had a fully differentiated phenotype, subsequent studies using adult cells
from cows did use differentiated cells (Wells et al 1999). Adult somatic cells
have also been used to derive clones in mice (Wakayama et al 1998).

Figure 2. Schematic outline of the nuclear transfer procedure. Oocytes
derived from Scottish Blackface (symbolised as a yellow sheep) are enucleated.
The donor cell derived from a different sheep breed (symbolised as a red sheep)
is placed under the zona pelucida into the perivitelline space. The cell
nucleus is introduced into the cytoplast by electrofusion, which also activates
the oocyte. The reconstructed embryo is then either cultured in vitro up to
blastocyst stage or is transferred into a pseudopregnant intermediate recipient
ewe. At day 7 embryos are assessed for development. Late morulae and
blastocysts are transferred into final recipients. Pregnancies resulting from
nuclear transfer are determined by ultrasound scan at about 60 days after
oestrus and development is subsequently monitored at regular intervals.

Figure 3. Regression analysis of
mean TRF lengths in NT sheep and controls. Graph showing the telomere length
decline with age for control sheep (solid circles) and NT animals together with
the fitted line (solid) and 95% prediction interval for an additional
observation at any given age (dashed line).
B. Observations on ageing in ovine clones.
Initial investigations
into ageing in cloned animals has revolved around an examination of telomeres
in sheep (Shiels et al 1999a, 1999b). These experiments asked if the generation
of animals without germline involvement results in the resetting of telomere
lengths and hence any molecular clock which measured time by such lengths.
Three cloned animals were
examined, whose derivation spanned
distinct developmental stages and cell types. These comprised animal 6LL3,
(“Dolly”), derived by
transfer of a nucleus from ovine mammary epithelial (OME) cells from a 6 year
old sheep, 6LL6 from sheep
embryonic cells (SEC 1) obtained from day 9 embryos, and 6LL7 which was derived
from fibroblasts from a
day 25 fetus. All three animals showed apparent telomere diminution as
determined by measurement of
mean terminal restriction
fragment (TRF) lengths. The TRF
diminution observed in 6LL3 was the greatest of the three animals
and was consistent with the age of her progenitor ovine mammary tissue (6 years
old) and significantly the time OME cells derived from that tissue, spent in
culture prior to nuclear transfer.
The influence of time
spent by donor cells in culture is
substantial. Telomere shortening due to enhanced damage attributed to reactive
oxygen species (ROS)in vitro, has
previously been reported (Von Zglinicki et al , 1995; Zijlmanset al., 1997). The full effect
of such oxidative damage,
however, is only manifest
subsequently, in any clone derived
from such cells. The
contribution of in vitro culture to telomere erosion in sheep derived by nuclear transfer,
superimposed on the age of progenitor tissue, could be gauged from the TRF
diminution of OME cells that had undergone up to 27 population doublings (9
passages)in culture. When compared to the mammary gland from which these cells
derived and to Dolly, derived in turn from these cells after 3 population
doublings, a mean TRF decrease was observed at an average 0.157 kb per
population doubling. The immediate implication of these observations is that
the extent of TRF shortening can be mitigated, principally by minimising time in culture and the age of
donor cells. This is particularly relevant with respect to animal 6LL7, where
the use of fetal tissue and minimal culturing yielded an animal where the mean TRF size is not
significantly shorter than age matched controls, unlike 6LL3 and 6LL6 where culturing was more prolonged (Figure
3).
The most likely
explanation for the shorter mean TRF lengths of all three nuclear transfer
sheep is that the TRF size observed reflects that of the transferred nucleus.
Whether this telomere erosion is reflected in the overall ageing process of
these animals is uncertain. It is not known whether the actual physiological
age of animals derived by nuclear transfer is accurately reflected by TRF
measurement. No physiological progeria has yet been reported in any animal
derived by nuclear transfer. Veterinary examination of the cloned animals has
confirmed that they are healthy and typical for sheep of their age and breed,
despite having a shorter mean TRF length.
Furthermore, 6LL3 has undergone two normal pregnancies and successfully
delivered healthy lambs.
The telomere hypothesis
of ageing (Olovnikov, 1973; Cooke and Smith, 1986; Harley, 1991; Bodnar et
al ,
1998), however, would predict that
animal 6LL3 would reach a critical telomere length sooner than age matched
controls. However, ovine TRFs show a large size distribution, from 5-50Kb
(Shiels et al 1999a,b), thus it
remains to be seen whether a critical length will be reached during the
animal’s lifetime. Experimental inactivation of murine telomerase only
produced a phenotype after five generations (Blasco et al 1997; Lee et al 1998)
and similar observations have been made in telomerase deficient yeast cells
(Lundblad and Blackburn, 1993).
It is noteworthy, in
respect of the inverse correlation between telomere length and lifespan, that
the TRF spread in sheep appears to fall between those of mouse and man in
accord with the hypothesis that longer telomeres mean a shorter lifespan.
Clarification of whether
telomere erosion is causative for, or an effect of the ageing process is not
immediately apparent. The observations on cloned sheep are, however, congruent
with the redox theory of ageing (Ozawa 1995,1997) which would predict that the
vigour and fecundity of such animals would be physiologically identical to age
matched controls.
IV. Cause and effect:
testing the models of ageing.
Mitigation of the
observed effects of both ageing and in vitro senescence do seem feasible. It is this capacity which will allow dissection of the
component parts of the ageing process and illustrates the potential of nuclear
transfer as a tool to achieve this. Strategies for remedial action can be
detailed as follows.
Introduction of telomerase to normal human cells in
culture has been reported to significantly increase their lifespan (Bodnar et
al,
1998).
Ectopic expression of the
telomerase catalytic subunit (hTERT) and subsequent activation of telomerase in
postsenescent cells has been demonstrated to allow the cells to proliferate
beyond crisis (Counter et al 1999).
Furthermore, alteration of the carboxyl terminus of hTERT appears not to
affect telomerase enzymatic activity, though it prevents telomere maintenance
and consequent cell proliferation. Cells expressing hTERT ectopically appear
phenotypically normal and exhibit no manifestations of malignant transformation
(Jiang et al 1999; Morales et al 1999).
While these observations
indicate a strong correlation between telomere erosion and the timing of
cellular senescence, how this will be integrated within a complete description
of the chronological ageing phenotype has yet to be determined. Any
extrapolation beyond consideration of telomere length as one feature of a
mitotic clock would seem to be premature.
While telomere erosion
can be directly addressed experimentally, it has still to be fully established
how such hTERT expressing cells will fare in vivo. A key consideration in this context ,
will be the effect of any genetic damage acquired in vitro (and for that matter in
vivo)
which is not accessible to telomerase repair. Another consideration is whether
oxidative damage is primarily manifest as telomere erosion, due to telomere
sequence content or cellular localisation.
A donor nucleus source
which is naturally telomerase positive, such as a lymphocyte, might be a better
choice to mitigate the effects of telomere erosion without recourse to genetic
manipulation. Such a cell type, however, might be considered unsuitable as a
donor source, as telomerase positivity is often a characteristic of malignancy.
Telomerase positivity coupled with the increased risk of in vitro accrued oxidative
damage, means that the chances of neoplastic transformation are increased.
Quantification of this risk, however,
is not straightforward and requires species specific model systems to address the issue (for a
fuller discussion see Colman 1999). Suitable model systems have not yet been established.
Parenthetically, it is not known whether
outbreeding a cloned animal or inter breeding clones will restore telomere
lengths. In the former instance, the presence of the chromosome complement from
the naturally derived parent would provide a haploid complement of full length telomeres, while in the
latter germline resetting of telomere lengths would be required. It is unknown
if germline resetting of telomeres occurs in interbred clones. This is
presently being investigated.
Another aspect of telomere
erosion in mammals that needs clarification is the relationship between this
phenomenon and that of extrachromosomal rDNA circle generation as described in
yeast (Sinclair et al, 1997). A comparison of Dolly with a relevant control
panel of sheep should prove informative in this context, as the nucleolar model
would predict that she should at least reflect the age of her progenitor
tissue. This is supported by analysis of terminal restriction fragment lengths
(Shiels et al, 1999a,b).
A final consideration
with regard to telomeres is whether there is a causal relationship between age
associated demethylation and telomere attrition.
If so, ameliorating
telomere shortening may mitigate loss of methylation and equally the generation
of extrachro-mosomal rDNA circles. It remains to be determined if this
hypothesis is valid.
While shortening time
spent in culture offers an immediate route to decreasing any telomere erosion due to reactive oxygen
species, this should also reduce genome wide oxidative damage. Calorific restriction offers a second
means of mitigating oxidation effects, with a proven efficacy in vitro and in vivo (Hass et al, 1993; Sohal
et al, 1994).
A number of issues
pertaining to the source, extent and contribution of such oxidative damage can
now be brought into focus. Mitochondrial damage contributing to the overall
ageing process, as postulated within “the redox mechanism of
ageing” (Ozawa, 1995, 1997)
is both amenable to direct investigation and redress.
Mitochondria in cloned animals almost entirely derive from the recipient
oocyte cytoplasm (Evans et al 1999), hence problems arising as a consequence of
the higher mutation rate in mitochondria and their accumulation, particularly
in post-mitotic cells, are circumvented. If the tenet of this hypothesis is
valid then one would expect animals derived by nuclear transplantation from
adult cell sources not to show the physiological characteristics of the age of
their progenitor, but to reflect that of age control animals. Only genomic damage acquired by the
donor nucleus should be transferred to clones and manifested accordingly.
The physiological
characteristics of Dolly and other sheep clones (Wilmut et al 1997; Shiels et
al 1999a,b) and the failure to detect premature ageing in cloned mice (Wakayama
et al 1999) are in keeping with such a hypothesis, whereby damage to
mitochondria is a key event in the physiological degeneration associated with
ageing.
Genomic damage inherited
by the clones is not easily redressed. As the accumulation of deleterious
somatic mutations correlates positively with increasing age, there is a greater
likelihood of acquiring damage to developmentally important genes through the
use of older donor cell sources. This obviates the practical choice of using nuclei
from younger cell sources as donors for nuclear tranplantation.
Assessment of the
relative consequences of
mitochondrial and genomic oxidative damage and nuclear-mitochondrial
communication within the ageing process,
can also be addressed by manipulation of nuclear encoded mitochondrial
genes and to some extent, by variation of the recipient cytoplasm. This should allow determination of to
what extent accumulation of mutations in the nucleus contributes to age related
mitochondrial dysfunction.
V. Conclusions.
Molecular gerontology is,
if you excuse the pun, rapidly coming of age. Recent advances in nuclear
transplantation technology (for a review see Colman 1999) have provided a
direct route to the investigation of the individual processes that give rise to
the ageing phenotype and for the first time allowed their direct testing in
vivo.
The manipulation of such processes, using the full panoply of molecular techniques and the powerful genetics
available for studies in mice, should allow for a fuller understanding of
ageing from the level of the single cell to the whole organism. The potential to mitigate the effects
of these processes exists in the laboratory, though the practical application
of this technology is not so easily achieved. One immediate application of this
technology is the development of Cellular therapies for countering the effects
of diseased or degenerating tissues. This would comprise the molecular
manipulation of cells in vitro , repairing for example, telomere erosion, replacing
deleterious alleles of age important genes, upregulating oxygen free radical
scavengers, or replacement of damaged mitochondria. Such cells could, for
example, be used to supplement or
replace cells in failing organs.
Consequently, the functional replacement of degenerating tissues may no
longer fall within the realms of science fiction.
I would like to
acknowledge Alan Colman, Ian Garner, Angelika Schnieke, Alex Kind and Keith
Campbell for helpful discussions and critical reading of the manuscript
References
Adelman R, Saul RL, Ames
BN (1988). Oxidative damage to DNA: relation
to species metabolic rate and life span. Proc Natl Acad Sci U S A 85:2706-8
Alexander P (1967). The role of DNA lesions in
processes leading to ageing in mice. Symp. Soc. Exp. Biol. 21:29-50.
Allsopp RC, Vaziri H,
Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB (1992). Telomere length
predicts replicative capacity of human fibroblasts. Proc. Nat. Acad. Sci.
USA 89: 10114-10118
Ashworth D, Bishop, M,
Campbell, KHS, Colman A, Kind, AJ, Schnieke AE, Blott, S, Griffin H, Haley C, McWhir J, Wilmut I (1998). DNA microsatellite
analysis of Dolly. Nature 394: 329.
Austriaco NR Jr, Guarente LP (1997) Changes in telomere
length cause reciprocal changes
the lifespan of mother cells in Saccharomyces cerevisiae. Proc. Nat.
Acad. Sci. USA 94: 9768-9772.
Baguisi A, Behboodi E,
Melican DT, Pollock JS, Destrempes MM, Cammuso C, Williams JL,Nims SD, Porter
CA, Midura P, Palacios MJ, Ayres SL, Denniston RS, Hayes ML, Ziomek CA, Meade
HM, Godke RA, Gavin WG, Overstrom EW, Echelard Y. (1999) Production of goats by
somatic cell nuclear transfer. Nat Biotechnol. 17: 456-61.
Blasco MA, Lee HW, Hande
MP, Samper E, Lansdorp PM, DePinho RA, Greider CW (1997) Telomere shortening and
tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34.
Bodnar AG, Ouellette M,
Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S,
Wright WE (1998) Extension of life-span by introduction of telomerase into normal human
cells. Science 279 : 349-352Campbell KHS (1999) Nuclear equivalwence,
Nuclear transfer and the cell cycle Cloning 1: 3-15.
Campbell KH, McWhir J,
Ritchie WA, Wilmut I (1996) Sheep cloned by nuclear transfer from a cultured cell
line. Nature 380: 64-6
Cathcart R, Schwiers E,
Saul RL, Ames B (1984) Thymine glycol and thymidine glycol in human and rat
urine: apossible assay for oxidative DNA damage. Proc Natl Acad Sci U S A 81:5633-7
Cooke HJ, Smith BA (1986) Variability at the
telomeres of the human X/Y pseudoautosomalregion. Cold Spring Harb.
Symp.Quant. Biol. LI, 213-219.
Cheng R, Murano S, Kurz B,
Schmookler-Reis R (1990) Homologous recombination is elevated in some Werner like
syndromes but not during normal in vitro or in vivo senescence of mammalian
cells. Mut. Res 237: 259-269
Cibelli JB, Stice SL, Golueke PJ, Kane JJ,
Jerry J, Blackwell, C, Ponce de Leon FA, Robl JM (1998). Cloned transgenic
calves produced from nonquiescent fetal fibroblasts. Science 280: 1256-1258.
Colman A (1999) Mammalian somatic cell
cloning: progress and applications. Nat. Genet (in press)
Counter CM, Hahn WC, Wei
W, Caddle SD, Beijersbergen RL, Lansdorp PM, Sedivy JM, Weinberg RA (1998) Dissociation among in
vitro telomerase activity, telomere maintenance, and cellular immortalization.
Proc Natl Acad Sci U S A 95:
14723-14728
de Lange T (1992)Human telomeres are
attached to the nuclear matrix. EMBO J. 11: 717-724.
Esposito LA, Melov S,
Panov A, Cottrell BA, Wallace DC (1999) Mitochondrial disease in mouse
results in increased oxidative stress. Proc Natl Acad Sci U S A 96: 4820-4825.
Evans MJ,Gurer C, Loike
JD, Schnieke AE, Schon EA (1999) Mitochondrial genotypes in nuclear transfer derived
cloned sheep. Nature : in press
Frenck RW Jr, Blackburn
EH, Shannon KM (1998) The rate of telomere sequence loss in human leukocytes
varies with age. Proc Natl Acad Sci U S A 95: 5607-5610.
Fraga CG, Shigenaga MK,
Park JW, Degan P, Ames BN (1990) Oxidative damage to DNA during aging:
8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci U
S A 87:
4533-4537.
Fukuchi K , Martin G,
andMonnat R (1989) Mutator phenotype of Werner’s syndrome is
characterised by extenasive deletions. Proc Natl Acad Sci U S A 86: 5893-5897.
Gompertz B (1825). On the nature of the
function expressive of the law of human mortality, and on the mode of
determining life contingencies. Phil. Trans. Roy. Soc. 115: 513-585.
Gottschling DE, Zakian VA (1986) Telomeric proteins:
specific recognition and protection of the natural termini of Oxitricha
macronuclear DNA. Cell 47: 195-205
Gray MD, Shen JC,
Kamath-Loeb AS, Blank A, Sopher BL, Martin GM, Oshima J, Loeb LA (1997) The Werner syndrome
protein is a DNA helicase. Nat. Genet. 17: 100-103.
Gray MD, Jesch SA, Stein
GH (1991)
5-Azacytidine-induced demethylation of DNA to senescent level does not block
proliferation of human fibroblasts. J. Cell Physiol. 149:477-84
Griffith JD, Comeau L,
Rosenfield S, Stansel RM, Bianchi A, Moss H, de Lange T (1999) Mammalian telomeres end
in a large duplex loop. Cell 97 503-514.
Guarente L (1997) Link between aging and
the nucleolus. Genes and Dev. 11: 2449-2455
Harley CB (1991) Telomere loss: mitotic
clock or genetic time bomb? Mutat Res. 256: 271-282.
Harley CB, Futcher, AB, Greider CW (1990) Telomeres shorten during ageing of
human fibroblastsNature 345: 458-460.
Hass BS, Hart RW, Lu MH,
Lyn-Cook BD (1993) Effects of calorific restriction in animals on cellular
function, oncogene expression, and DNA methylation in vitro. Mutat Res 295: 281-289
Hayakawa M, Hattori K,
Sugiyama S, Ozawa T (1992) Age-associated oxygen
damage and mutations in mitochondrial DNA in human hearts. Biochem Biophys
Res Commun
189: 979-985.
Hayakawa M, Sugiyama S,
Hattori K, Takasawa M, Ozawa T (1993) Age-associated damage in
mitochondrial DNA in human hearts. Mol Cell Biochem 119: 95-110
Hayflick L, Moorehead PS (1961). The serial cultivation
of human diploid strainsExp. Cell. Res. 25: 585-621.
Jiang XR, Jimenez G, Chang
E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD, Chiu CP
(1999)
Telomerase expression in human somatic cells does not induce changes associated
witha transformed phenotype. Nat Genet 21: 111-114.
Kennedy BK, Gotta M,
Sinclair DA, Mills K, McNabb DS, Murthy M, Pak SM, Laroche T, Gasser SM,
Guarente L (1997) Redistribution of silencing proteins from telomeres to the
nucleolus is associated with extension of lifespan in S, cerevisiae Cell 89: 381-391.
Kipling D, Cooke HJ (1990). Hypervariable
ultra-long telomeres in mice. Nature 347: 400-402.
Kunisada T, Miller CD,
Schneider EL (1990) Ultraviolet light-induced DNA damage in transcribed
sequences: nochange in repair with age. Mutat Res 237: 75-81.
Kuro-o M, Matsumura Y,
Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y,
Kurabayashi M, Kaname T,
Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI (1997) Mutations of the mouse
klotho gene leads to a synderome resembling ageing. Nature 390: 45-51
Lee HW, Blasco MA,
Gottlieb GJ, Horner JW 2nd, Greider CW, DePinho RA (1998). Essential role of mouse
telomerase in highly proliferative organs. Nature 329: 569-574
Linnane AW, Baumer A,
Maxwell RJ, Preston H, Zhang CF, Marzuki S (1990) Mitochondrial gene mutation: the
ageing process and degenerative diseases. Biochem Int 22: 1067-1076.
Linnane AW, Marzuki S,
Ozawa T, Tanaka M (1989) Mitochondrial DNA mutations as an important contributor to
ageingand degenerative diseases. Lancet 1: 642-645
Luder A and Mosig G (1982) Two alternative
mechanisms for the initiation forks in bacteriophage t4: priming by RNA polymerase
and by recombination. Proc Natl Acad Sci U S A 79: 1101-1105
Lundblad V, Blackburn EH (1993) An alternative pathway
for yeast telomere maintenace rescues est-1 senescence. Cell 73: 347-360. Menzies RA, Gold PH (1971) The turnover of
mitochondria in a variety of tissues in young adult and aged rats. J. Biol.
Chem 246:
2425-2429
Morales CP, Holt SE,
Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE, Shay J (1999) Absence of
cancer-associated changes in human fibroblasts immortalized with telomerase.
Nat Genet 21: 115-118.
Mote PL, Grizzle JM,
Walford RL, Spindler SR (1991) Influence of age and calorific restriction on
expression of hepatic genes for xenobiotic and oxygen metabolizing enzymes in
the mouse. J Gerontol 46: 95-100
Moyzis RK, Buckingham JM,
Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL,Wu JR (1988) A highly conserved
repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human
chromosomes. Proc Natl Acad Sci U S A 85: 6622-6
Oexle K, Zwirner A (1997). Advanced telomere
shortening in respiratory chain disorders. Human Mol. Genet. 6: 905-908.
Olovnikov AM (1973). A theory of
marginotomy. The incomplete copying of template margin in enzymic synthesis of
polynucleotides and biological significance of the phenomenon. J.Theor. Biol 41:181-190.
Osiewacz H.D (1997) Genetic regulation of
agingJ. Mol Med.75: 715-727.
Ozawa T (1995) Mechanism of somatic mitochondrial
DNA mutations associated with age and diseases. Biochim Biophys Acta. 1271:177-189.
Ozawa T (1997) Oxidative damage and
fragmentation of mitochondrial DNA in cellular apoptosis. Bioscience Reports 17: 237-250.
Ozawa T, Sahashi K, Nakase
Y, Chance B (1995) Extensive tissue oxygenation associated with mitochondrial
DNAmutations. Biochem Biophys Res Commun 213: 432-438.
Prowse, KR, Greider, CW (1995) Developmental and
tissue-specific regulation of mouse telomerase andtelomere length. Proc.
Natl. Acad. Sci. U.S.A. 92: 4818-4822.
Schnieke AE, Kind AJ,
Ritchie WA, Mycock K, Scott AR, Ritchie M, Wilmut I, Colman A,Campbell KH (1997) Human factor IX
transgenic sheep produced by transfer of nuclei from transfected fetal
fibroblasts. Science 278: 2130-2133
Shiels PG, Kind AJ,
Campbell KH, Waddington D, Wilmut I, Colman A, Schnieke AE (1999a) Analysis of telomere
lengths in cloned sheep. Nature 399: 316-317
Shiels PG, Kind AJ,
Campbell KH, Waddington D, Wilmut I, Colman A, Schnieke AE (1999b) Analysis of telomere
length in Dolly, a sheep derived by nuclear transfer. Cloning 1: 1-7.
Signer, EN, Dubrova, YE,
Jeffreys, AJ, Wilde, C, Finch, LM, Wells, DN, Misica, PM, Day, TA and
Tervit, HR (1997). DNA fingerprinting Dolly. Nature 394: 329-330.
Sinclair, DA, Guarente L (1997) Extrachromosomal rDNA circles-a cause of aging in yeast.
Cell
91:1033-1042
Sinclair DA, Mills K,
Guarente L (1997) Accelerated aging and nucleolar fragmentation inyeast sgs
1 mutants. Science 277: 1313-1316.
Sohal RS, Agarwal S,
Candas M, Forster MJ, Lal H (1994) Effect of age and calorific restriction on
DNA oxidative damage indifferent tissues of C57BL/6 mice. Mech Ageing Dev 76: 215-224.
Starling JA, Maule J,
Hastie, ND, Allshire, RC (1990). Extensive telomere repeat arrays in mouse are
hypervariable. Nucleic Acids Res 18 : 6881-6888.
Takasawa M, Hayakawa M,
Sugiyama S,Hattori K, Ito T, Ozawa T (1993) Age-associated damage in
mitochondrial function in rat hearts. Exp Gerontol 28: 269-280.
van Gool AJ; van der Horst
GTJ, Citterio E, Hoeijmakers J HJ (1997) Cockayne syndrome: defective repair
of transcription? EMBO J. 16: 4155-4162,.
von Zglinicki T, Saretzki
G, Docke W, Lotze C (1995) Mild hyperoxia shortens telomeres and inhibits
proliferation of fibroblasts: a model for senescence? Exp Cell Res 220:186-193.
Wakayama T, Perry AC,
Zuccotti M, Johnson KR, Yanagimachi R (1998) Full-term development of mice from
enucleated oocytes injected with cumulus cell nuclei. Nature 394: 369-374.
Wakayama T, Yanagimachi R
(1999)
Cloning the laboratory mouse Seminars in Cell and Dev Biol 10: 253-258.
Wells DN, Misica PM, Day
TA, Tervit H. (1997) Production of cloned lambs from an established embryonic
cell line: a comparison between in vivo- and in vitro-matured cytoplasts.
Biol. Reprod. 57: 385-393.
Wells DN, Misica PM,
Tervit HR (1999) Production of cloned calves following nuclear transfer
with cultured adult mural granulosa cells. Biol Reprod 60: 996-1005.
Williamson JR, Raghuraman
MK, Cech TR (1989) Monovalent cation induced structure of telomeric DNA: the
G quartet model. Cell 59: 871-880.
Wilmut I, Schnieke AE,
McWhir J, Kind AJ, Campbell KH. (1997) Viable offspring derived from fetal
and adult mammalian cells. Nature 385: 810-813.
Wilson VL, Jones PA (1983) DNA methylation
decreases in aging but not in immortal cells. Science 220: 1055-7
Wilson VL, Smith RA, Ma S,
Cutler RG (1987) Genomic 5-methyldeoxycytidine decreases with age. J
Biol Chem 262: 9948-51
Zijlmans JM, Martens UM,
Poon SS, Raap AK, Tanke HJ, Ward RK, Lansdorp PM (1997) Telomeres in the mouse
have large inter-chromosomal variations in the number of T2AG3 repeats. Proc
Natl Acad Sci U S A 94: 7423-7428.